o,p'-DDD (mitotane) treatment for Cushing's syndrome: adrenal drug concentration and inhibition in vitro of steroid synthesis.
o,p'-DDD is an inhibitor of adrenal steroid synthesis currently used for therapy of Cushing's syndrome. Conflicting data have been published on the relationship between the plasma level of the drug and its clinical and biological effects. The levels of o,p'-DDD and o,p'-DDE in various tissues obtained from treated patients have been measured and are compared with data on in vitro steroidogenesis in adrenal tissues from the same patients. o,p'-DDD was found in all samples and o,p'-DDE in half of them, both levels being high when the tissue lipid concentration was high. There was considerable variability in lipid content from one tissue to another and within a tissue from one sample to another; only the drug to lipid ratio seems able to provide a reproducible index of drug entry into a tissue. No relationship was found between the tissue concentration of the drug and the total dose administered or inhibition of the steroid biosynthetic step studied.
D019326:17-alpha-Hydroxyprogesterone; D000310:Adrenal Gland Neoplasms / Q000378:metabolism; D000311:Adrenal Glands / Q000378:metabolism*; D000328:Adult; D002277:Carcinoma / Q000378:metabolism; D002648:Child; D003350:Cortodoxone / Q000378:metabolism; D003480:Cushing Syndrome / Q000188:drug therapy* / Q000378:metabolism; D003900:Desoxycorticosterone / Q000378:metabolism; D003633:Dichlorodiphenyl Dichloroethylene / Q000378:metabolism; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000378:metabolism; D006965:Hyperplasia / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D008939:Mitotane / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D013256:Steroids / Q000096:biosynthesis*
D006908:Hydroxyprogesterones; D013256:Steroids; D003900:Desoxycorticosterone; D003633:Dichlorodiphenyl Dichloroethylene; D019326:17-alpha-Hydroxyprogesterone; D008939:Mitotane; D003350:Cortodoxone